Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Translational Research : the Journal of Laboratory and Clinical Medicine|December 4, 2014
Targeting of type I interferon in systemic autoimmune diseasesMary K Crow, Mikhail Olferiev, Kyriakos A KirouAnnual Review of Pathology|October 18, 2018
Type I Interferons in Autoimmune DiseaseMary K Crow, Mikhail Olferiev, Kyriakos A KirouArthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and TreatmentMary K Crow, Mikhail Olferiev, Kyriakos A KirouTransactions of the American Clinical and Climatological Association|September 3, 2015
Identification of Candidate Predictors of Lupus FlareMary K Crow, Mikhail Olferiev, Kyriakos A KirouNature Reviews. Rheumatology|September 4, 2024
Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapyYogita Ghodke-Puranik, Mikhail Olferiev, Mary K CrowJournal of Clinical Immunology|May 28, 2004
Inhibitory Fc gamma receptors: from gene to diseaseRadu N Stefanescu, Mikhail Olferiev, Yi Liu, et al.Methods in Molecular Biology (Clifton, N.J.)|February 6, 2014
Measuring interferon alpha and other cytokines in SLEMikhail Olferiev, Mari Lliguicota, Kyriakos A Kirou, et al.Clinical Immunology (Orlando, Fla.)|August 31, 2016
Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosusMikhail Olferiev, Elzbieta Jacek, Kyriakos A Kirou, et al.The Journal of Biological Chemistry|November 30, 2006
The role of activating protein 1 in the transcriptional regulation of the human FCGR2B promoter mediated by the -343 G -> C polymorphism associated with systemic lupus erythematosusMikhail Olferiev, Emi Masuda, Shizuko Tanaka, et al.Iscience|June 1, 2026
An NT5E loss-of-function variant permits tissue inflammation and hypertension in systemic lupus erythematosusIsaac Peabody, Mikhail Olferiev, Katherine A Owen, et al.Pageof 1